We have investigated the association of the recently identified IL6R polymorphisms with the serum levels of soluble IL-6 receptor (sIL-6R). sIL-6R is generated by shedding of the membrane-bound receptor (IL-6Ra) or alternative mRNA splicing. In total, 115 healthy volunteers were genotyped, with 70 of them analyzed for sIL-6R levels. Using the PCR/RFLP methods, two important polymorphic sites were selected for genotyping: the 48892A/C (D358A) in exon 9 and the À183G/A in the promoter region. In exon 9, C allele carriers had higher sIL-6R level (Po0.0001) showing that this sequence variation, which corresponds to the proteolytic cleavage site of IL-6Ra, strongly influences the serum sIL-6R levels. In the promoter region, G allele carriers had lower sIL-6R levels (Po0.0082) compared with the A allele carriers. This could be attributed to the linkage disequilibrium (D 0 ¼ 0.54, w 2 ¼ 51.3, Po0.0001) between the À183G/A and the 48892A/C gene polymorphisms.
Introduction
In 1988, Interleukin-6 receptor (IL-6R) was isolated and its molecular structure was determined. 1 Genes that encode IL-6R were located on chromosomes 1q21 and 9 2 although the latter was found out to be a pseudogene. 3 IL-6R exists in a membrane-associated and soluble form (sIL-6R). Two mechanisms have been reported on the generation of sIL-6R. The first mechanism involves proteolytic cleavage or shedding of the membrane-bound form, 4 and the second form, which represents a small fraction of the total sIL-6R present in the human serum, consists of alternative mRNA splicing resulting in a transcript encoding a soluble receptor. 5, 6 The cleavage site was determined at one major location (Gln357/Asp358) close to the transmembrane region of the protein. 7 Shedding may be enhanced by bacterial pore-forming toxins, 8 phorbol ester, 4 formyl peptide 9 and others. On the other hand, high-level production of alternatively spliced soluble IL-6R was detected in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy. IL6-Ra cloning methods by Yamasaki et al 1 predicted a cDNA consisting of 468 amino-acid protein with a leader peptide of 19 amino acids, a transmembrane domain of 28 amino acids and a short intracytoplasmic tail of 82 amino acids. Cells that do not express IL-6R in their surface like early extramedullary hematopoetic progenitor cells, 10 endothelial, 11 most of the erythroid and megakaryocytic progenitor cells 12 can only be stimulated by the IL-6/sIL-6R complex. It was also shown that IL-6 dependent myeloma cells were unable to grow in the presence of low IL-6 concentrations when the medium was depleted of sIL-6R produced by these cells. 13 Increased levels of sIL-6R has been found in sera of patients with inflammatory bowel disease, 14 lymphoid malignancies, 15 rheumatoid arthritis 16 and periodontitis 17 among others. Recently, seven novel single nucleotide polymorphisms (SNPs) were identified by Kim et al 18 from 300 healthy Korean volunteers. This has led to the inception of this study to determine if these polymorphisms would have any significant effect on the level of soluble IL-6R in the serum. Two important polymorphic sites were selected: the À183G/A polymorphism in the promoter region and 48892A/C in exon 9.
Results and discussion
The distribution of the IL-6R gene polymorphisms is indicated in Table 1 . Promoter and exon 9 alleles were designated as previously described: 18 G and A and A and C, respectively. Haplotype and linkage disequilibrium analyses (SNPAlyzet ver 3.1, Dynacom Japan) revealed that 41.6, 31.6, 17.1 and 9.7% of the subjects were GA, AC, GC and AA haplotypes, respectively, and the two sites were in linkage disequilibrium (D ¼ 0.11, D 0 ¼ 0.54, w 2 ¼ 51.3 and Po0.0001). There was a highly significant correlation between the serum levels of sIL-6R and the IL6R genotypes after analysis with KruskalWallis test (Po0.0001 in exon 9, Po0.018 in promoter). In exon 9, highly significant results between the genotypes were obtained after analysis with Wilcoxon test (Figure 1a ) and adjustment with Bonferroni's correction. Genotype differences significantly influenced the serum levels of sIL-6R, with around 1.7-fold increase in serum sIL-6R between the A/A and the C/C genotypes. The mean7values in ng/ml were: A/A 23.871.0, A/C 29.771.4, C/C 39.772.8. Significant results were also noted after grouping the subjects by age (younger group (n ¼ 36) from 20 to 31 years, and older group (n ¼ 34) from 40 years and above) and by gender (male, n ¼ 30 and female, n ¼ 40) (data not shown). Carriers of the C allele had higher levels of serum sIL-6R than those who were homozygous to the A allele after analysis with Mann-Whitney U-test (Po0.0001).
In the promoter region, significant serum sIL-6R differences between the A/A and G/G, and A/A and A/G genotypes were also noted (Figure 1b) after analysis with Wilcoxon test. However, after adjustment with Bonferroni's correction, only the sIL-6R level between the A/A and G/G genotypes were significant. When divided into groups by age and gender, only the female subjects had a significant difference between the genotypes after analysis with Kruskal-Wallis test (Po0.046). G allele carriers had lower serum sIL-6R level than the A allele carriers after analysis with Mann-Whitney U-test (Po0.0082).
No difference was noted between the distribution of the polymorphisms in the Korean group 18 and this study in the Japanese. It is worth emphasizing that the 48892A/C SNP in exon 9 results in an amino-acid substitution from Aspargine to Alanine (D358A). 18 Polymorphisms resulting in amino acid substitution in other genes like the leptin receptor gene or LEPR (Q223R) produced a truncated receptor lacking in transmembrane and intracellular domains, 19 with individuals homozygous or heterozygous to the mutation having higher serum leptin levels. 20 In the case of IL6R, no previous studies investigating the effect of the mutation on the length of the receptor have been reported yet, but basing on the ELISA results, the exon 9 polymorphism strongly influenced the serum sIL-6R levels. Mü llberg et al 7 established the proteolytic cleavage site of IL-6Ra in the same location as the amino-acid substitution, and their studies have revealed that cells of various origins expressing the membranebound form are capable of quantitatively shedding the IL-6R making shedding, as opposed to alternative mRNA splicing, likely to be the mechanism by which the naturally occurring sIL-6R is generated. Incorporating this with the significant results of this study on systematically healthy subjects, it can be hypothesized that this sequence variation has a remarkable effect on the shedding of IL-6R, with the C allele carriers shedding more membrane-bound receptors than the non-C allele carriers. In total, 115 genomic DNA samples were isolated from the peripheral blood of healthy volunteers (42 males and 73 females) with a mean age of 43.3 years (range: 22-77 years) using a DNA extraction kit (Wako Pure Chemical Industries. Inc., Osaka, Japan). All subjects were of Japanese descent and nonsmokers as determined by a standard questionnaire. All procedures were performed in accordance with the Helsinki protocol and with the guidelines set by the Niigata University Ethical Committee. Polymorphisms within the IL-6R gene (GenBank Sequence Accession ID: X58298) were genotyped by PCR/RFLP. Primers for the amplification and sequencing analysis were designed based on the sequence of human chromosome 1q (Genbank ID: NT_079484). In total, 70 ng of sample DNA were amplified in a 25 ml volume of the reaction mixture containing 10 Â reaction buffer, 1. The higher serum sIL-6R in À183 A allele carriers can be clearly attributed to the linkage disequilibrium of this locus with the 48892 A/C sequence variation in exon 9. However, it could also be hypothesized that the position of this promoter polymorphism, which falls in the NF-I binding site, one of the putative transcription factor binding sites of this gene, 18 could have an effect on gene transcription. NF-I proteins and binding sites have been implicated in both activation and repression of promoters, which consequently affects gene transcription through multiple mechanisms. 21 This study documents the strong influence of the sequence variations in the IL-6R gene to the serum levels of sIL-6R. This is an interesting finding in view of the important role of sIL-6R in the regulation of IL-6 responses, but further studies in different ethnic groups, functional analyses and association to disease progression and severity of the SNPs studied are encouraged to confirm and extend our observations. Figure 1 Relationship between IL-6R gene polymorphisms and serum soluble IL-6R (sIL-6R) level. Out of the 115 IL6R genotyped subjects, 70 were randomly selected for the analysis of serum soluble IL-6 levels using the commercially available Quantikinet ELISA kits (R&D Systems, Wiesbaden-Nordenstadt, Germany). Sample preparation was carried out according to the manufacturer's instructions. The assays were analyzed in duplicate with the mean minimum detectable dose set at 0.0065 ng/ml (NS ¼ not significant).
